Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection

Abstract Introduction The aim of this work was to quantify the effects of injection volume at different technetium-99m specific radiotracer doses on its lymphatic movement in animal model. Procedures Effects of injection volume (50, 100 μl) at different doses (0.05, 0.135, 0.22 nmol) on popliteal no...

Full description

Saved in:
Bibliographic Details
Published in:Nuclear medicine and biology Vol. 39; no. 1; pp. 145 - 153
Main Authors: Núñez, Eutimio Gustavo Fernández, de Oliveira, Erica Aparecida, da Silva, Natanael Gomes, de Oliveira Filho, Renato Santos
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 2012
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Introduction The aim of this work was to quantify the effects of injection volume at different technetium-99m specific radiotracer doses on its lymphatic movement in animal model. Procedures Effects of injection volume (50, 100 μl) at different doses (0.05, 0.135, 0.22 nmol) on popliteal node (PN) detection were studied in rats. The radiotracer under study was99m Technetium-cysteine-mannose-dextran conjugate (30 kDa). Results At 0.05 nmol dose, higher PN uptake was observed at 50 μl injection volume (2.6 fold increase). Conversely, at 0.135 nmol dose, an increase of radiotracer retention in PN was achieved at 100 μl volume, 78% higher than 50 μl. However, at 0.22 nmol dose, the injection volume changes did not influence on the PN uptake. Considering as suitable radiotracer performance: high PN uptake and extraction, better combinations were 0.05 nmol/50 μl, 0.135 nmol/100 μl, 0.22/50 μl. Conclusion Suitable performances could be reached by proper combinations of dose, injection volume and concentration for a specific radiotracer used in sentinel lymph node detection.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0969-8051
1872-9614
DOI:10.1016/j.nucmedbio.2011.07.004